Calculates first-order elimination half-life from two post-distribution concentrations and sample times.
Drug Half-Life from Two Concentrations: Clinical Guide
Browse Knowledge HubCalculates first-order elimination half-life from two post-distribution concentrations and sample times. This clinical guide covers appropriate use, calculation, interpretation, limitations and practical safeguards.
Overview
Calculates first-order elimination half-life from two post-distribution concentrations and sample times.
Clinical Significance
The estimate assumes post-distribution first-order decline. It is frequently used in therapeutic drug monitoring but requires exact sampling and dosing history.
When to Use
- Estimate half-life from two valid concentrations on the elimination phase.
- Use exact collection times.
- Confirm stable renal function and no intervening dose.
How It Is Calculated
- First calculate k = ln(C1/C2) ÷ Δt, then half-life = ln(2) ÷ k.
- The calculator validates the required inputs before applying the equation and rounds only the displayed result.
Interpretation
- The estimate assumes post-distribution first-order decline. It is frequently used in therapeutic drug monitoring but requires exact sampling and dosing history.
- Review the component values and assumptions as well as the final result.
Worked Example
Enter clinically plausible values in the stated units. MedicalC applies: First calculate k = ln(C1/C2) ÷ Δt, then half-life = ln(2) ÷ k. Review the displayed result against the source data and the relevant clinical pathway.
Patient Considerations
- Confirm that the patient and clinical setting match the population or physiologic assumptions behind the equation.
- Consider whether treatment, organ function, pregnancy, body composition, sampling conditions or acute illness materially alter interpretation.
- Use serial calculations only when methods and units remain comparable.
Limitations
- Distribution-phase sampling overestimates elimination.
- Changing kidney function or dialysis invalidates the estimate.
- Two concentrations do not prove one-compartment behaviour.
Clinical Pearls
- Review the concentration-time plot when more samples are available.
- Use the same time unit throughout.
- Recalculate after a material change in clearance.
Common Mistakes
- Using scheduled rather than actual sample times.
- Including a concentration drawn during infusion or distribution.
- Ignoring an additional dose between samples.
Evidence Base
The implementation uses the published or established relationship: First calculate k = ln(C1/C2) ÷ Δt, then half-life = ln(2) ÷ k. The cited source should be reviewed alongside current specialty guidance before clinical deployment.
Frequently Asked Questions
What does the Drug Half-Life from Two Concentrations calculator do?
Calculates first-order elimination half-life from two post-distribution concentrations and sample times.
Can the result be used by itself?
No. The result is clinical decision support and must be interpreted with the source measurements, patient context and current guidance.
What most commonly makes the result unreliable?
Using scheduled rather than actual sample times.
When should the calculation be repeated?
Repeat it when a relevant input, sampling condition, treatment or clinical state changes.
Does the calculator replace direct measurement or specialist review?
No. Use direct measurement, validated software or specialist review whenever the clinical decision requires greater precision.
References
- Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions. J Pharmacokinet Biopharm. 1976. — Primary publication, authoritative guideline or recognised clinical source supporting the calculation.
Reviewed by: MedicalC Clinical Editorial Team
Last reviewed: July 2026
Clinical Disclaimer
MedicalC calculators and clinical tools are intended to support healthcare professionals. They do not replace clinical judgement, individual patient assessment, local guidance or specialist advice.
Results should always be interpreted in the context of the patient’s history, examination, investigations, current clinical condition and applicable professional guidance.